| cpd00572 | 1358996-45-8 | N-terminal aldehyde peptide | GGGGRGDS | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI |
cpd00573 | 1358996-44-7 | ketone containing peptide | KGGGHVWMQAP | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI | cpd00574 | 1358996-43-6 | N-terminal aldehyde peptide | GGGPNRHS | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI | cpd00575 | 1358996-42-5 | N-terminal aldehyde peptide | GGGPHSRN | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI | cpd00576 | 1358996-37-8 | ketone containing peptide | KGGGAMPVQWH | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI | cpd00577 | 1358996-36-7 | N-terminal aldehyde peptide | GGGGRGDS | ureidopyrimidinone (UPy) | Synthesis, self-assembly, control over the position and availability of bioactive molecules in biomaterials | amide | Kieltyka, Roxanne E.et.al (2012)
DOI | cpd00578 | 1034334-81-0 | inhibitor peptide | EVNXVAEFXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00579 | 1268472-49-6 | inhibitor peptide | EVNXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00580 | 1268472-48-5 | inhibitor peptide | EVNXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00581 | 1268472-47-4 | inhibitor peptide | EVNXVAEFXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00582 | 1268472-46-3 | inhibitor peptide | EVNXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00583 | 1408065-74-6 | inhibitor peptide | EVNXVAEFXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00584 | 1408065-73-5 | inhibitor peptide | EVNXVAEFXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00585 | 1408065-72-4 | inhibitor peptide | EVNXVAEFXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00586 | 1408065-71-3 | inhibitor peptide | EVNXVAEFXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00587 | 1408065-70-2 | inhibitor peptide | EVNXVAEFXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00588 | 1408065-69-9 | inhibitor peptide | EVNXVAEFXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00589 | 1408065-68-8 | inhibitor peptide | EVNXVAEFXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00590 | 1408065-67-7 | inhibitor peptide | EVNXVAEF | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00591 | 1408065-66-6 | inhibitor peptide | EVNXVAEFXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00592 | 1408065-65-5 | inhibitor peptide | EVNXVAEFXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00593 | 1408065-64-4 | inhibitor peptide | EVNXVAEFXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00594 | 1408065-57-5 | inhibitor peptide | EVNXVAEFXXXXXD | Cholestanol | Neurodegenerative, Azheimer's disease, BACE1 inhibition | amide | Linning, Philipp;et.al (2012)
DOI | cpd00595 | 1382799-83-8 | endothelial cell epitope | RGDFK | Diethyl squarate | Synthesis | amide | Araujo, Ana Catarina;et.al (2012)
DOI | cpd00596 | 1382799-80-5 | endothelial cell epitope | RGDFK | Diethyl squarate | Synthesis | amide | Araujo, Ana Catarina;et.al (2012)
DOI | cpd00597 | 1382799-77-0 | endothelial cell epitope | GRGDS | Diethyl squarate | Synthesis | amide | Araujo, Ana Catarina;et.al (2012)
DOI | cpd00598 | 1367281-27-3 | tripeptide | GLK | 1,5,9-Triazacyclododecane-1-acetic acid | Synthesis | carbamoyl | Li, Zhi-et.al (2012)
DOI | cpd00599 | 1367281-26-2 | tripeptide | GLW | 1,5,9-Triazacyclododecane-1-acetic acid | Synthesis | carbamoyl | Li, Zhi-et.al (2012)
DOI | cpd00600 | 1367281-25-1 | tripeptide | GLY | 1,5,9-Triazacyclododecane-1-acetic acid | Synthesis | carbamoyl | Li, Zhi-et.al (2012)
DOI | cpd00601 | 1367281-24-0 | tripeptide | GLF | 1,5,9-Triazacyclododecane-1-acetic acid | Synthesis | carbamoyl | Li, Zhi-et.al (2012)
DOI | 
